Transplantation tolerance: the big picture. Where do we stand, where should we go?
A major goal in organ transplantation has been to safely exploit the natural processes of immune tolerance in order to minimize the dose and duration of drug immunosuppression. In this commentary, I argue that we can learn from how tumours avoid rejection, to evolve a three-stage tolerance-inducing...
第一著者: | Waldmann, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2017
|
類似資料
-
Transplantation tolerance-where do we stand?
著者:: Waldmann, H
出版事項: (1999) -
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
著者:: Inês Barros, 等
出版事項: (2020-10-01) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
著者:: Aqeel M. Alenazi, 等
出版事項: (2023-04-01) -
ColVI myopathies: where do we stand, where do we go?
著者:: Allamand Valérie, 等
出版事項: (2011-09-01) -
Training Needs Assessment: Where We Are and Where We Should Go
著者:: Rodrigo Rezende Ferreira, 等
出版事項: (2013-01-01)